Glycologix

A clinical stage company developing a biopolymer device, GLX-100, as a new standard for the underserved millions suffering with a serious bladder condition.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Beverly, MA, USA
  • Currency USD
  • Founded June 2016
  • Employees 3
  • Incorporation Type C-corp
  • Website glycologix.com

Company Summary

Glycologix is in a clinical trial with GLX-100, a biopolymer device being developed as a gold standard treatment for the underserved millions with interstitial cystitis/bladder pain syndrome. Data are expected in Q4'24 which will enable Series A funding to fund a pivotal clinical trial and pursue partnership and/or acquisition.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free